Idexx Laboratories Inc
IDXXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Idexx Laboratories Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 18 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 2, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Clearstead Trust, LLC | 2026-03-31 | 1,486 | $835K | SEC filing |
| Dorsey & Whitney Trust CO LLC | 2026-03-31 | 486 | $273K | SEC filing |
| EARNED WEALTH ADVISORS, LLC | 2026-03-31 | 416 | $234K | SEC filing |
| Crewe Advisors LLC | 2026-03-31 | 1 | $562 | SEC filing |
| Genus Capital Management Inc. | 2026-03-31 | 2,522 | $1.42M | SEC filing |
| RITHOLTZ WEALTH MANAGEMENT | 2026-03-31 | 8,643 | $4.86M | SEC filing |
| OSSIAM | 2026-03-31 | 7,337 | $4.12M | SEC filing |
| Corient Private Wealth LLC | 2026-03-31 | 122,006 | $68.5M | SEC filing |
| CONGRESS ASSET MANAGEMENT CO | 2026-03-31 | 166,686 | $93.7M | SEC filing |
| MassMutual Private Wealth & Trust, FSB | 2026-03-31 | 411 | $231K | SEC filing |
| ONTARIO TEACHERS PENSION PLAN BOARD | 2026-03-31 | 4,887 | $2.75M | SEC filing |
| Jump Financial, LLC | 2026-03-31 | 5,430 | $3.05M | SEC filing |
| Gallacher Capital Management LLC | 2026-03-31 | 660 | $371K | SEC filing |
| Dana Investment Advisors, Inc. | 2026-03-31 | 980 | $551K | SEC filing |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 2026-03-31 | 510 | $287K | SEC filing |
| Martin Capital Advisors, LLP | 2026-03-31 | 4,113 | $2.31M | SEC filing |
| Groupe la Francaise | 2026-03-31 | 6,461 | $3.63M | SEC filing |
| EXENCIAL WEALTH ADVISORS, LLC | 2026-03-31 | 652 | $367K | SEC filing |
| DT Investment Partners, LLC | 2026-03-31 | 62 | $34.8K | SEC filing |
| Capital Research Global Investors | 2026-03-31 | 781,345 | $439M | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Idexx Laboratories Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-02-26 · MAZELSKY JONATHAN JAY: Larger than 34 of the 37 other insider sales of Common Stock on file. SEC filing
- 2026-02-26 · MAZELSKY JONATHAN JAY: Larger than 35 of the 37 other insider sales of Common Stock on file. SEC filing
- 2026-02-26 · MAZELSKY JONATHAN JAY: Larger than 36 of the 37 other insider sales of Common Stock on file. SEC filing
- 2025-11-07 · Hunt Nimrata: Larger than all 37 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-03 | Hunt Nimrata · Executive Vice President | Common Stock | S — Open market or private sale | −1,758 | 634.57 | SEC filing |
| 2026-02-26 | MAZELSKY JONATHAN JAY · President and CEO | Common Stock | S — Open market or private sale | −3,660 | 658.92 | SEC filing |
| 2026-02-26 | MAZELSKY JONATHAN JAY · President and CEO | Common Stock | S — Open market or private sale | −1,200 | 661.10 | SEC filing |
| 2026-02-26 | MAZELSKY JONATHAN JAY · President and CEO | Common Stock | S — Open market or private sale | −1,095 | 651.49 | SEC filing |
| 2026-02-26 | MAZELSKY JONATHAN JAY · President and CEO | Common Stock | S — Open market or private sale | −1,488 | 655.85 | SEC filing |
| 2026-02-26 | MAZELSKY JONATHAN JAY · President and CEO | Common Stock | S — Open market or private sale | −2,589 | 663.04 | SEC filing |
| 2026-02-26 | MAZELSKY JONATHAN JAY · President and CEO | Common Stock | S — Open market or private sale | −1,669 | 652.49 | SEC filing |
| 2026-02-26 | MAZELSKY JONATHAN JAY · President and CEO | Common Stock | S — Open market or private sale | −1,343 | 656.85 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-01 | FENNELL GEORGE · Executive Vice President | Common Stock | M — Exercise or conversion of derivative security | +639 | SEC filing |
| 2026-06-01 | FENNELL GEORGE · Executive Vice President | Restricted Stock Unit | M — Exercise or conversion of derivative security | −639 | SEC filing |
| 2026-06-01 | FENNELL GEORGE · Executive Vice President | Common Stock | F — Payment of exercise price or tax by delivering securities | −284 | SEC filing |
| 2026-05-12 | HOOLEY JOSEPH L · Director | Deferred Stock Unit | A — Grant, award, or other acquisition | +234 | SEC filing |
| 2026-05-12 | HOOLEY JOSEPH L · Director | Non-Qualified Stock Option (right-to-buy) | A — Grant, award, or other acquisition | +525 | SEC filing |
| 2026-05-12 | Vandebroek Sophie V. · Director | Non-Qualified Stock Option (right-to-buy) | A — Grant, award, or other acquisition | +525 | SEC filing |
| 2026-05-12 | SAMAD SAM · Director | Deferred Stock Unit | A — Grant, award, or other acquisition | +234 | SEC filing |
| 2026-05-12 | Claflin Bruce L. · Director | Non-Qualified Stock Option (right-to-buy) | A — Grant, award, or other acquisition | +525 | SEC filing |
Showing 8 of 33 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.